English | Español

Boehringer-Ingelheim
Carol Ostrow | Dec 15, 2017

Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson | Feb 25, 2017

Combination therapy targets lung cancer
Carol Ostrow | Feb 19, 2017

Partnership spurs efforts against COPD
Amanda Rupp | Jun 28, 2016

Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp | Jun 5, 2016

Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp | May 31, 2016

Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp | May 25, 2016

BioMed X, Boehringer Ingelheim partner for psychiatric treatments

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval